Condition (MeSH)
Status Asthmaticus
ClinicalTrials.gov lists 33 trials for Status Asthmaticus or a narrower condition beneath it. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
33 of the 33 trials are tagged with Status Asthmaticus itself; the rest are tagged with a narrower condition beneath it.
When did Status Asthmaticus trials start? (20)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2023 | 1 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 1 |
| 2018 | 3 |
| 2017 | 2 |
| 2016 | 3 |
| 2015 | 3 |
Showing 10 of 20 earlier years.
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Status Asthmaticus trials in? (8)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 3 |
| Phase 1/2 | 1 |
| Phase 2 | 5 |
| Phase 2/3 | 3 |
| Phase 3 | 1 |
| Phase 4 | 6 |
| Not applicable | 11 |
| Observational | 3 |
How many Status Asthmaticus trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 14 |
| Terminated | 5 |
| Withdrawn | 7 |
| Unknown status | 6 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Status Asthmaticus trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2 |
| Amphastar Pharmaceuticals, Inc. | 1 |
| Hill-Rom | 1 |
Which drugs are being tested for Status Asthmaticus? (3)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Montelukast | 3 |
| Albuterol | 3 |
| METHYLPREDNISOLONE | 2 |
Interventions as named in the registry (12)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Dexamethasone/Dexamethasone acetate | 3 |
| Double distilled water | 2 |
| NaCl 0.9% NS | 2 |
| Standard Care | 1 |
| epinephrine inhalation aerosol, CFC propelled | 1 |
Showing 5 of 12 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Status Asthmaticus trials report? (2)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Exacerbation of asthma | 6 | 1 |
| Pneumonia | 1 | 1 |
Which publications cover Status Asthmaticus? (30)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Volatile anaesthetic for treatment of respiratory failure from status asthmaticus requiring extracorporeal membrane oxygenation. | BMJ case reports | 2020 | Yes |
| Clinical Phenotypes of Atopy and Asthma in COPD: A Meta-analysis of SPIROMICS and COPDGene. | Chest | 2020 | Yes |
| Adjunct Therapies for Refractory Status Asthmaticus in Children. | Respiratory care | 2017 | Yes |
| Response to nebulized salbutamol versus combination with ipratropium bromide in children with acute severe asthma. | JPMA. The Journal of the Pakistan Medical Association | 2016 | Yes |
| Albuterol via metered-dose inhaler in children: Lower doses are effective, and higher doses are safe. | Pediatric pulmonology | 2016 | Yes |
Showing 5 of 30 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.